Commonly prescribed GLP-1 receptor agonists in the UK include: Semaglutide (Ozempic, Wegovy, Rybelsus [oral formulation]) Dulaglutide (Trulicity) Liraglutide (Victoza, Saxenda) Exenatide (Byetta [twice-daily], Bydureon [weekly]) Tirzepatide (Mounjaro) - a dual GIP/GLP-1 receptor agonist with similar considerations [6] [7] These medications are typically administered via subcutaneous injection (daily, twice-daily or weekly depending on the specific formulation), with semaglutide also available as an oral tablet
Dissolution typically takes 1-5 minutes
Recent studies say that retatrutide works with GIP to lower blood sugar and help with weight loss
In Conclusion While they are highly effective at accelerating weight loss, GLP-1 therapies compromise muscle mass and skin integrity, leading to decreased tone, volume loss, and laxity
Yale Medicines obesity medicine specialists can help you decide whats best based on your individual health history and goals
GLP-1: broadening the incretin concept to involve gut motility
